ArticleMolecular medicine reports2015

Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.

Yuqi Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.